Cargando…

Cerebellar volume as imaging outcome in progressive multiple sclerosis

BACKGROUND AND PURPOSE: To assess whether cerebellar volumes changes could represent a sensitive outcome measure in primary-progressive MS. MATERIAL AND METHODS: Changes in cerebellar volumes over one-year follow-up, estimated in 26 primary-progressive MS patients and 20 controls with Freesurfer lon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Inglese, Matilde, Petracca, Maria, Mormina, Enricomaria, Achiron, Anat, Straus-Farber, Rebecca, Miron, Shmuel, Fabian, Michelle, Krieger, Stephen, Miller, Aaron, Lublin, Fred, Sormani, Maria Pia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5402974/ https://www.ncbi.nlm.nih.gov/pubmed/28437430 http://dx.doi.org/10.1371/journal.pone.0176519

Ejemplares similares

A composite measure to explore visual disability in primary progressive multiple sclerosis
por: Poretto, Valentina, et al.
Publicado: (2017)

Cerebellum and neurodegenerative diseases: Beyond conventional magnetic resonance imaging
por: Mormina, Enricomaria, et al.
Publicado: (2017)

Synchronization and variability imbalance underlie cognitive impairment in primary-progressive multiple sclerosis
por: Petracca, Maria, et al.
Publicado: (2017)

Relationship between timed 25-foot walk and diffusion tensor imaging in multiple sclerosis
por: Klineova, Sylvia, et al.
Publicado: (2016)

Association Between White Matter Microstructure and Verbal Fluency in Patients With Multiple Sclerosis
por: Blecher, Tal, et al.
Publicado: (2019)

Monitoring Progressive Multiple Sclerosis with Novel Imaging Techniques
por: Petracca, Maria, et al.
Publicado: (2018)

The relationship between cortical lesions and periventricular NAWM abnormalities suggests a shared mechanism of injury in primary-progressive MS
por: Pardini, Matteo, et al.
Publicado: (2017)

Cerebellar amelanotic melanoma can mimic cerebellar abscess in a pediatric case of neurocutaneous melanosis
por: Mormina, Enricomaria, et al.
Publicado: (2021)

Optimizing multiple sclerosis diagnosis: gene expression and genomic association
por: Gurevich, Michael, et al.
Publicado: (2015)

Static Posturography and Falls According to Pyramidal, Sensory and Cerebellar Functional Systems in People with Multiple Sclerosis
por: Kalron, Alon, et al.
Publicado: (2016)

Gray Matter Correlates of Cognitive Performance Differ between Relapsing-Remitting and Primary-Progressive Multiple Sclerosis
por: Jonkman, Laura E., et al.
Publicado: (2015)

Phase-Sensitive Inversion-Recovery MRI Improves Longitudinal Cortical Lesion Detection in Progressive MS
por: Harel, Asaff, et al.
Publicado: (2016)

Classification of multiple sclerosis patients based on structural disconnection: A robust feature selection approach
por: Schiavi, Simona, et al.
Publicado: (2022)

An Italian programme for COVID-19 infection in multiple sclerosis
por: Sormani, Maria Pia
Publicado: (2020)

CD19+ B cell values predict the increase of anti-SARS CoV2 antibodies in fingolimod-treated and COVID-19-vaccinated patients with multiple sclerosis
por: Schiavetti, Irene, et al.
Publicado: (2023)

Sensory‐motor network topology in multiple sclerosis: Structural connectivity analysis accounting for intrinsic density discrepancy
por: Schiavi, Simona, et al.
Publicado: (2020)

Can Blood Gene Expression Predict Which Patients with Multiple Sclerosis Will Respond to Interferon?
por: Kaminski, Naftali, et al.
Publicado: (2005)

Transcriptional response to interferon beta-1a treatment in patients with secondary progressive multiple sclerosis
por: Gurevich, Michael, et al.
Publicado: (2015)

Injury to white matter tracts in relapsing–remitting multiple sclerosis: A possible therapeutic window within the first 5 years from onset using diffusion-tensor imaging tract-based spatial statistics
por: Asaf, Achiron, et al.
Publicado: (2015)

Effects of teriflunomide treatment on cognitive performance and brain volume in patients with relapsing multiple sclerosis: Post hoc analysis of the TEMSO core and extension studies
por: Sprenger, Till, et al.
Publicado: (2022)

Relapsing experimental allergic encephalomyelitis an autoimmune model of multiple sclerosis
por: Lublin, Fred D.
Publicado: (1985)

Molecular Profiling of Glatiramer Acetate Early Treatment Effects in Multiple Sclerosis
por: Achiron, Anat, et al.
Publicado: (2009)

Emergency Medical Care of Multiple Sclerosis Patients: Primary Data from the Mount Sinai Resource Utilization in Multiple Sclerosis Project
por: Oynhausen, Svenja, et al.
Publicado: (2014)

Optical Coherence Tomography Is Associated With Cognitive Impairment in Multiple Sclerosis
por: Dreyer-Alster, Sapir, et al.
Publicado: (2022)

Secondary Prevention in Radiologically Isolated Syndromes and Prodromal Stages of Multiple Sclerosis
por: Amato, Maria Pia, et al.
Publicado: (2022)

Static posturography across the EDSS scale in people with multiple sclerosis: a cross sectional study
por: Kalron, Alon, et al.
Publicado: (2016)

COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021
por: Achiron, Anat, et al.
Publicado: (2021)

Retrospective unbiased plasma lipidomic of progressive multiple sclerosis patients-identifies lipids discriminating those with faster clinical deterioration
por: Amatruda, Mario, et al.
Publicado: (2020)

Objective and subjective measures of dalfampridine efficacy in clinical practice
por: Klineova, Sylvia, et al.
Publicado: (2018)

Quantifying Gait Impairment Using an Instrumented Treadmill in People with Multiple Sclerosis
por: Kalron, Alon, et al.
Publicado: (2013)

COVID-19 vaccination in patients with multiple sclerosis: Safety and humoral efficacy of the third booster dose
por: Dreyer-Alster, Sapir, et al.
Publicado: (2022)

Sleep disturbance and memory dysfunction in early multiple sclerosis
por: Sumowski, James F., et al.
Publicado: (2021)

Differential antibody response to COVID-19 vaccines across immunomodulatory therapies for multiple sclerosis
por: Satyanarayan, Sammita, et al.
Publicado: (2022)

Suppressed RNA-Polymerase 1 Pathway Is Associated with Benign Multiple Sclerosis
por: Achiron, Anat, et al.
Publicado: (2012)

Defining the clinical course of multiple sclerosis: The 2013 revisions
por: Lublin, Fred D., et al.
Publicado: (2014)

Prediction of acute multiple sclerosis relapses by transcription levels of peripheral blood cells
por: Gurevich, Michael, et al.
Publicado: (2009)

The Effect of Body Mass Index on Brain Volume and Cognitive Function in Relapsing–Remitting Multiple sclerosis: A CombiRx Secondary Analysis
por: Ben-Zacharia, Aliza Bitton, et al.
Publicado: (2021)

Assessing heterogeneity of treatment effect in multiple sclerosis trials
por: Sormani, Maria Pia, et al.
Publicado: (2023)

Regional Cerebellar Volume Loss Predicts Future Disability in Multiple Sclerosis Patients
por: Parmar, Katrin, et al.
Publicado: (2021)

Uveitis prior to clinical presentation of Multiple Sclerosis (MS) is associated with better MS prognosis
por: Raskin, Eyal, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mf2e31o9v9i5912m7vc1c8akgh